Bill Aliski

Inga fler pågående positioner

77 år

Health Technology

Commercial Services

Consumer Services

Profil

William E.
Aliski formerly worked at Ultragenyx Pharmaceutical, Inc., as Independent Director from 2011 to 2022, Scioderm, Inc., as Director, X4 Pharmaceuticals, Inc., as Independent Director from 2019 to 2025, Beacon Therapeutics (USA), Inc., as Director from 2018 to 2022, Simon-Kucher & Partners GmbH, as Director from 2008 to 2009, Edimer Pharmaceuticals, Inc., as Director, Transkaryotic Therapies, Inc., as Vice President-Commercial Operations, BioMarin Pharmaceutical, Inc., as General Manager-BioMarin Europe from 2005 to 2008, Genzyme Corp., as Vice President-Patient & Product Services, FoldRx Pharmaceuticals LLC, as Chief Commercial Officer & Senior Vice President from 2009 to 2011, and BioMarin Europe Ltd., as General Manager.
Mr. Aliski received his graduate degree in 1969 from Boston College and graduate degree in 1987 from Harvard Kennedy School of Government.

Tidigare kända positioner av Bill Aliski

Företag	Position	Slut
X4 PHARMACEUTICALS, INC.	Direktör/Styrelseledamot	2025-06-09
APPLIED GENETIC TECHNOLOGIES CORPORATION	Direktör/Styrelseledamot	2022-12-01
ULTRAGENYX PHARMACEUTICAL INC.	Direktör/Styrelseledamot	2022-06-24
FoldRx Pharmaceuticals LLC FoldRx Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Provides drug discovery and clinical development services	Företagsledare/Principal	2011-03-01
Simon-Kucher & Partners GmbH Simon-Kucher & Partners GmbH Miscellaneous Commercial ServicesCommercial Services Provides strategy, marketing and pricing consulting services	Direktör/Styrelseledamot	2009-06-01

Se detaljerna i Bill Aliskis erfarenhet

Bill Aliskis utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Bill Aliskis erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	13
Transkaryotic Therapies, Inc. Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets biopharmaceutical products	Commercial Services
BioMarin Pharmaceutical, Inc. BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions	Health Technology
Genzyme Corp. Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology	Health Technology
FoldRx Pharmaceuticals LLC FoldRx Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Provides drug discovery and clinical development services	Health Technology
Ultragenyx Pharmaceutical, Inc. Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases	Health Technology
Scioderm, Inc. Scioderm, Inc. BiotechnologyHealth Technology Engages in the development of innovative therapies for areas of high unmet need, including orphan products	Health Technology
Boston College Boston College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Beacon Therapeutics (USA), Inc. Beacon Therapeutics (USA), Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical research and development company that provides gene therapy development & clinical research services	Health Technology
Simon-Kucher & Partners GmbH Simon-Kucher & Partners GmbH Miscellaneous Commercial ServicesCommercial Services Provides strategy, marketing and pricing consulting services	Commercial Services
Edimer Pharmaceuticals, Inc. Edimer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical products for improving the health and quality of life of families living with XLHED	Health Technology
BioMarin Europe Ltd. BioMarin Europe Ltd. BioMarin Europe Ltd. specializes in developing and marketing therapies for serious genetic and rare diseases. The company is based in Wilton Place, Ireland. The Irish company offers eight approved enzyme and gene therapy products for conditions such as achondroplasia, severe hemophilia A, lysosomal storage disorders, and other rare inherited metabolic and genetic diseases. Its pipeline includes clinical-stage and preclinical investigational medicines in areas such as central nervous system, cardiovascular, musculoskeletal/metabolic, and non-oncology hematology, using modalities like biologics, gene therapies, oligonucleotides, peptides, and small molecules. BioMarin Europe supports expanded access programs for investigational products, conducts clinical trials for rare genetic and metabolic conditions, and provides medical information services, safety monitoring, and mechanisms for reporting adverse events and product complaints.
Harvard Kennedy School of Government Harvard Kennedy School of Government Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
X4 Pharmaceuticals, Inc. X4 Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases	Health Technology